Not enough is currently known about the long-term safety and rate of breakdown of the soyabean oil in the filling and its possible effects on the body.
Further assessment is underway.
NHS hospitals and private clinics have been advised by the Medical Devices Agency and the Department of Health not to use any more Trilucent TM breast implants and to return stocks to the supplier. Some of these included reports of swelling generally associated with implant rupture. The underlying cause of the swelling is unknown but it may be due to a local inflammatory response. This local swelling is believed to resolve once the ruptured implant has been removed. There has been no evidence of permanent injury or harm to general health.